Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01297530
Recruitment Status : Terminated
First Posted : February 16, 2011
Last Update Posted : July 30, 2013
Information provided by:

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2012
  Study Completion Date : July 2012